Healthcare IT teams need single Sign-On solutions that supports HIPAA obligations, keeps PHI encrypted in transit and at rest, and produces the access and audit evidence a compliance review asks for. The products below are the closest fit for regulated healthcare environments.
No product in this category matches the healthcare IT filter yet, so all 12 are listed below.
Back to all Single Sign-On Solutions tools, or browse the full software directory. You can also run head-to-head comparisons or read about our review methodology.
For background on scoring, see how rankings work. Our editorial articles add deeper analysis, the glossary clarifies vendor terminology, and our calculators help estimate ROI before the shortlist narrows further.
Nothing in this category met the healthcare IT filter, so the full single Sign-On solutions category is listed here instead.
Usage-based pricing · Cloud · Free trial
The rule engine is what developers reach for, since login flows can be customized per application instead of being standardized across an entire estate. Teams building multi-tenant SaaS or consumer-facing products get the most out of that flexibility. Enterprise identity governance is the weaker fit, and usually lands on a dedicated identity and access management platform with stronger lifecycle management.
Custom quote · Cloud
Depth in privileged access management is what separates CyberArk Identity from identity and access management products that stop at workforce single sign-on, which it also covers. The primary fit is enterprise teams carrying formal privilege management requirements, particularly in regulated industries such as finance and healthcare.
Per-user · Cloud · Free trial
Self-service enrollment is the practical detail in Duo, since users register their own devices and a rollout does not queue up at the help desk. Device trust is the capability that separates it from simpler OTP tokens, checking whether an endpoint meets security policy before access is granted. Licensing is per user, and hybrid work environments are where that device check earns its place.
Device-based · Cloud · Free trial
Organizations moving workloads off on-prem infrastructure use JumpCloud as the practical stand-in for Active Directory. Device management, single sign-on, MFA, and LDAP/RADIUS services come from one cloud directory, so identity and device administration do not need separate products. Device-based pricing covers Windows, macOS, and Linux alike.
Open source · Cloud / On-prem · Free trial
Keycloak covers OIDC, SAML and LDAP integration and is commonly deployed as the SSO layer and identity broker inside an organization's own network. There is no commercial license to buy, on-prem or in containers. The cost reappears as internal expertise. Operating and maintaining the server falls entirely to the team that deploys it.
Per-user · Cloud · Free trial
SSO, MFA, Conditional Access and device identity cover Microsoft 365 and the thousands of third-party applications already integrated with it. For organizations already invested in Microsoft's stack, Entra ID usually becomes the identity layer by default instead of being chosen against alternatives. Licensing is per user and the service runs entirely from Microsoft's cloud.
Per-user · Cloud · Free trial
SAML and OIDC integrations that larger identity platforms charge extra to connect are included here, and that is what miniOrange is best known for. SMB and mid-market teams get workforce SSO, customer identity and MFA from a single vendor, covering both employee and end-customer logins, at per-user pricing that stays accessible at their scale.
Per-user · Cloud · Free trial
Breadth of pre-built application integrations is why Okta is usually the first name on the list for workforce single sign-on. Lifecycle management comes with it. Pricing is per-user, with significant differences between tiers. Modeling both current headcount and the figure 18 months out is the step teams skip before they sign.
Per-user · Cloud · Free trial
SmartFactor authentication is OneLogin's distinguishing piece, scoring the context of an access request before deciding how much proof to ask for. Single sign-on and MFA sit around it. Mid-market and enterprise teams that find Okta pricing aggressive often look here next. The application catalog is broad, and per-user cost tends to come out more competitive at mid-market scale.
Custom quote · Cloud · Free trial
Workforce and customer identity sit in the same product line at PingOne. That breadth shapes who evaluates it. Enterprise teams needing identity governance alongside single sign-on tend to put Ping next to Okta and Microsoft Entra. Mid-market buyers have a harder time modeling the cost, since pricing is quoted case by case.
Custom quote · Cloud
RSA ID Plus carries MFA and identity management into the installed base RSA has long held across financial services, defense and government. Organizations that ran SecurID hardware tokens historically and now want cloud-based MFA tend to look here first, helped by the existing relationship and the migration path on offer. Commercial terms come by quote.
Custom quote · Cloud
Large organizations in financial services, healthcare and defense are effectively the only buyers, because periodic access review is a compliance obligation there and someone has to produce auditable evidence of who holds which entitlement. Access certification, role management and separation-of-duties enforcement are the working parts, delivered from the cloud on quoted terms.
PHI encryption at rest and in transit, granular access control, audit logging detailed enough for regulatory review, and a vendor willing to sign a Business Associate Agreement covering how the data is handled.
There is no official HIPAA certification for software. What matters is whether the vendor signs a Business Associate Agreement, encrypts PHI, provides audit logging, and supports access controls that satisfy the HIPAA Security Rule.
Start with whether a Business Associate Agreement is available, then work through data residency, network segmentation, compliance reporting depth, and whether the product can run inside restricted clinical network segments.
